Effects of the Soy Phytoestrogen Genistein

Total Page:16

File Type:pdf, Size:1020Kb

Effects of the Soy Phytoestrogen Genistein EFFECTS OF THE SOY PHYTOESTROGEN GENISTEIN ON THE REPRODUCTIVE DEVELOPMENT OF IMMATURE FEMALE BROILER CHICKENS Except where reference is made to the work of others, the work described in this thesis is my own or was done in collaboration with my advisory committee. This thesis does not include proprietary or classified information. ________________________________________ Lindsay Marie Stevenson Certificate of Approval: ________________________ _______________________ Joseph B. Hess Wallace D. Berry, Chair Professor Associate Professor Poultry Science Poultry Science ________________________ _______________________ John P. Blake George T. Flowers Professor Interim Dean Poultry Science Graduate Schoool THE EFFECTS OF THE SOY PHYTOESTROGEN GENISTEIN ON THE REPRODUCTIVE DEVELOPENT OF IMMATURE FEMALE BROILER CHICKENS Lindsay Marie Stevenson A Thesis Submitted to the Graduate Faculty of Auburn University in Partial Fulfillment of the Requirements for the Degree of Master of Science Auburn, Alabama May 10, 2007 EFFECTS OF THE SOY PHYTOESTROGEN GENISTEIN ON THE REPRODUCTIVE DEVELOPMENT OF IMMATURE FEMALE BROILER CHICKENS Lindsay Marie Stevenson Permission is granted to Auburn University to make copies of this thesis at its discretion, upon request of individuals or institutions and at their expense. The author reserves all publication rights. ______________________________ Signature of Author ______________________________ Date of Graduation iii VITA Lindsay Marie Stevenson, daughter of John Alvin and Colleen Marie Stevenson, was born May 30, 1982 in Toledo, Ohio. She graduated from Lake High School in Millbury, Ohio in June 2000. She attended The Ohio State University in Columbus, Ohio majoring in Animal Sciences with a minor in Agricultural Business. She graduated in June 2004 with a Bachelor of Science in Agriculture degree. In August 2004, she entered Graduate School at Auburn University under the direction of Wallace Berry, Ph.D. iv THESIS ABSTRACT THE EFFECTS OF THE SOY PHYTOESTROGEN GENISTEIN ON THE REPRODUCTIVE DEVELOPMENT OF IMMATURE FEMALE BROILER CHICKENS Lindsay Marie Stevenson Master of Science, May 10, 2007 (Bachelor of Science, The Ohio State University, 2004) 152 Typed Pages Directed by Wallace D. Berry Developmentally inappropriate exposures to estrogenic compounds are known to alter morphology and function of the reproductive tract in various species. Chickens are continually exposed to the relatively potent estrogenic soy isoflavones through the diet. It has been shown that the primary soy isoflavone genistein induces proliferation of the chick oviduct. However, information is lacking as to the specific reproductive tract developmental effects of genistein exposure in chicks. Three experiments were done to compare specific oviduct morphological and functional responses to genistein exposure with responses elicited by a classical estrogen, diethylstilbestrol (DES) in female broiler chicks. To avoid the effects of dietary soy v isoflavones, the experimental diets were formulated with dried egg white, rather than the usual soybean meal, as a protein source. These experiments examined the effects of genistein in the on the morphology and growth of the oviduct and functional responses to estrogen consisting of plasma vitellogenin content and oviductal ovalbumin synthesis. From the three experiments, it was determined that genistein acts as a weak estrogen in the immature female chick. It has effects on the growth and morphology of the oviduct. Genistein can also induce the synthesis of estrogen-dependent secretions in the chick including vitellogenin and ovalbumin. vi ACKNOWLEDGEMENTS The author would like to express sincere appreciation to her graduate committee, Drs. Joseph Hess and John Blake for their input and support. Special thanks are extended to Dr. Wallace Berry for his instruction and guidance throughout the project. Thanks are also extended to the faculty and staff of the Poultry Science Department especially to Ms. Suzanne Oates for her help with laboratory procedures and preparations. The author would also like to thank her friends at Auburn and her fellow graduate students, Alexis, Candace, Gina, Leslie and Scott, for all of their support and assistance. Thanks are also due to Dr. Fred Hoerr and the staff at the Alabama Veterinary Diagnostics Laboratory for embedding and sectioning oviduct sections. This manuscript is dedicated to the author’s parents, John and Colleen Stevenson, and siblings, Nichole and Matthew, for always being there. vii Journal style used: Poultry Science Computer software used: Microsoft Office 2000® iPhoto 4.0.3© SAS 9.1® viii TABLE OF CONTENTS LIST OF TABLES xii LIST OF FIGURES xv CHAPTER I. INTRODUCTION 1 CHAPTER II. LITERATURE REVIEW 3 Estrogens 3 Endogenous Estrogens 3 Exogenous Estrogens 4 Estrogen Action 7 Estrogen Receptors 8 Estrogen Receptor Alpha 10 Estrogen Receptor Beta 11 Estrogen Receptor Gamma 12 Functions in Animals 12 Phytoestrogens 14 Sources of Phytoestrogens 14 Classes of Phytoestrogens 17 Coumestans 17 Lignans 17 Isoflavones 18 Soybean Phytoestrogens 19 ix General Effects on Animals 22 Genistein 24 Metablism 25 Analytical Methods to Determine Genistein Levels 26 Effects of Genistein 28 Molecular Effects 28 General Effects on Animals 30 Effects on Birds and Chickens 31 CHAPTER III. STATEMENT OF RESEARCH OBJECTIVES 37 CHAPTER IV. MANUSCRIPT 1 38 ESTROGENIC EFFECTS OF SHORT-TERM ORAL EXPOSURE TO THE SOY ISOFLAVONE GENISTEIN IN THE IMMATURE BROILER CHICKEN Abstract 38 Introduction 39 Materials and Methods 42 Results and Discussion 46 CHAPTER V. MANUSCRIPT 2 69 EFFECTS OF SHORT-TERM ORAL EXPOSURE TO THE SOY ISOFLAVONE GENISTEIN IN THE IMMATURE FEMALE BROILER CHICKEN Abstract 69 Introduction 70 Materials and Methods 73 Results and Discussion 77 CHAPTER VI. MANUSCRIPT 3 87 x EFFECTS OF SHORT-TERM INJECTED EXPOSURE TO THE SOY ISOFLAVONE GENISTEIN ON THE IMMATURE FEMALE BROILER CHICKEN Abstract 87 Introduction 88 Materials and Methods 91 Results and Discussion 95 CHAPTER VII. SUMMARY OF RESULTS 105 BIBLIOGRAPHY 107 APPENDICES 128 Appendix 1. Immunostaining of Paraffin Sections with Microwave 129 Antigen Retrieval Appendix 2. Bio-Rad Protein Assay 131 Appendix 3. Direct Enzyme Linked Immunosorbant Assay 132 Appendix 4. Sandwich Enzyme Linked Immunosorbant Assay 134 Appendix 5. Determining Total Isoflavones in Plasma with HPLC 136 xi LIST OF TABLES Table 1. Natural and synthetic xenoestrogens. 5 Table 2. Levels of isoflavones and lignans in various food sources. 15 Table 3. Various forms of isoflavones. 19 Table 4. Ingredient percentages and calculated analysis of broiler starter 51 diet with a low level of isoflavones. Table 5. Starting and final body weight. 52 Table 6. Oviduct weight and relative weight of the oviduct at 16 days 52 of age. Table 7. Wet femur weight and relative wet femur weight at 16 days 52 of age. Table 8. Dry femur weight and relative dry femur weight at 16 days 53 of age after 48 hours at 50°C. Table 9. Ashed femur weight and relative ashed femur weight at 16 53 days of age after 18 hours at 600°C. Table 10. Amount of protein and vitellogenin contained in the plasma 53 of birds at 16 days of age. Table 11. Ingredient percentages and calculated analysis of broiler starter 81 diet with a low level of isoflavones (control diet). Table 12. Ingredient percentages and calculated analysis of a standard 82 broiler starter diet (standard diet). Table 13. Average body weight per bird on days 0 and 5. 83 Table 14. Average body weight per bird on days 10 and 15. 83 xii Table 15. Average body weight gain per bird per period for days 0 to 5 83 and 5 to 10. Table 16. Average body weight gain per bird per period for days 10 to 15 84 and 0 to 15. Table 17. Liver weight and relative liver weight at 15 days of age. 84 Table 18. Oviduct weight and relative oviduct weight at 15 days of age. 84 Table 19. Wet femur weight and relative wet femur weight at 15 days 85 of age. Table 20. Dry femur weight and relative dry femur weight at 15 days 85 of age after 48 hours at 50°C. Table 21. Ashed femur weight and relative ashed femur weight at 15 days 85 of age after 18 hours at 600°C. Table 22. Amount of protein and vitellogenin contained in the plasma 86 of birds at 15 days of age. Table 23. Amount of genistein contained in the plasma of birds at 15 days 86 of age. Table 24. Ingredient percentages and calculated analysis of broiler starter 99 diet with a low level of isoflavones (control diet). Table 25. Ingredient percentages and calculated analysis of a standard 100 broiler starter diet (standard diet). Table 26. Average body weight per bird on days 0 and 5. 101 Table 27. Average body weight per bird on days 10 and 15. 101 Table 28. Average body weight gain per bird per period for days 0 to 5 101 and 5 to 10. Table 29. Average body weight gain per bird per period for days 10 to 15 102 and 0 to 15. Table 30. Liver weight and relative liver weight at 15 days of age. 102 Table 31. Oviduct weight and relative oviduct weight at 15 days of age. 102 Table 32. Wet femur weight and relative wet femur weight at 15 days 103 of age. xiii Table 33. Dry femur weight and relative dry femur weight at 15 days 103 of age after 48 hours at 50°C. Table 34. Ashed femur weight and relative ashed femur weight at 15 103 days of age after 18 hours at 600°C. Table 35. Amount of protein and vitellogenin contained in the plasma 104 of birds at 15 days of age. Table 36. Amount of genistein contained in the plasma of birds at 15 days 104 of age. xiv LIST OF FIGURES Figure 1. Structure of endogenous estrogens. 3 Figure 2. Structure of the synthetic estrogen diethylstilbestrol. 6 Figure 3. Structures of coumestans. 17 Figure 4. Structures of isoflavones. 19 Figure 5. Hemotoxylin and eosine stained paraffin embedded oviduct 54 sections from chicks at 16 days of age.
Recommended publications
  • Biologically Active Molecules from Soybeans
    10 Biologically Active Molecules from Soybeans Michio Kurosu Department of Pharmaceutical Sciences, University of Tennessee Health Science Center USA 1. Introduction Soybeans (Glycine max [L.] Merr.) contain an impressive array of biologically active components. People have been eating soybeans for almost 5,000 years. Unlike most plant foods, soybeans are high in protein. Researchers are interested in both the nutritional value and the potential health benefits of soybeans. Research of the health effects of soyfoods and soybean constituents has been received significant attention to support the health improvements or health risks observed clinically or in vitro experiments. This research includes a wide range of areas, such as cancer, coronary heart disease (cardiovascular disease), osteoporosis, cognitive function (memory related), menopausal symptoms, renal function, and many others. This chapter provides up-to-date coverage on biologically active and related organic molecules isolated from soy and soy products. Their biological activities are briefly summarized. Molecules discussed in this chapter are as follows: isoflavones, phytic acid, soy lipids, soy phytoalexins, soyasaponins, lectins, hemagglutinin, soy toxins, and vitamins. 2. Health benefit of soy or soy products Soy products have been considered as great source of protein for many decades. Japanese, in particular, eat a soy-based diet. Japanese monks eat soy products as their main protein source. They are known to live longer and have lower rates of chronic diseases. Because soybeans contain practically no starch, soybeans are an important part of a diabetic diet. Soybeans are 1) rich in protein (vide supra), calcium, and vitamins, and 2) high in mono- saturated fatty acids. In addition, soybeans contain several biologically interesting phytochemicals as minor components, which scientists are interested in understanding their biological functions.
    [Show full text]
  • Metabolomics and Transcriptomics Identify Multiple Downstream Targets of Paraburkholderia Phymatum Σ54 During Symbiosis with Phaseolus Vulgaris
    Research Collection Journal Article Metabolomics and Transcriptomics Identify Multiple Downstream Targets of Paraburkholderia phymatum σ54 During Symbiosis with Phaseolus vulgaris Author(s): Lardi, Martina; Liu, Yilei; Giudice, Gaetano; Ahrens, Christian H.; Zamboni, Nicola; Pessi, Gabriella Publication Date: 2018-04 Permanent Link: https://doi.org/10.3929/ethz-b-000258158 Originally published in: International Journal of Molecular Sciences 19(4), http://doi.org/10.3390/ijms19041049 Rights / License: Creative Commons Attribution 4.0 International This page was generated automatically upon download from the ETH Zurich Research Collection. For more information please consult the Terms of use. ETH Library International Journal of Molecular Sciences Article Metabolomics and Transcriptomics Identify Multiple Downstream Targets of Paraburkholderia phymatum σ54 During Symbiosis with Phaseolus vulgaris Martina Lardi 1, Yilei Liu 1, Gaetano Giudice 1, Christian H. Ahrens 2, Nicola Zamboni 3 and Gabriella Pessi 1,* ID 1 Department of Plant and Microbial Biology, University of Zurich, CH-8057 Zurich, Switzerland; [email protected] (M.L.); [email protected] (Y.L.); [email protected] (G.G.) 2 Agroscope, Research Group Molecular Diagnostics, Genomics and Bioinformatics & Swiss Institute of Bioinformatics (SIB), CH-8820 Wädenswil, Switzerland; [email protected] 3 Institute of Molecular Systems Biology, ETH Zurich, CH-8093 Zurich, Switzerland; [email protected] * Correspondence: [email protected]; Tel.: +41-44-6352904 Received: 28 February 2018; Accepted: 28 March 2018; Published: 1 April 2018 Abstract: RpoN (or σ54) is the key sigma factor for the regulation of transcription of nitrogen fixation genes in diazotrophic bacteria, which include α- and β-rhizobia.
    [Show full text]
  • The Pharmacologist 2 0 0 6 December
    Vol. 48 Number 4 The Pharmacologist 2 0 0 6 December 2006 YEAR IN REVIEW The Presidential Torch is passed from James E. Experimental Biology 2006 in San Francisco Barrett to Elaine Sanders-Bush ASPET Members attend the 15th World Congress in China Young Scientists at EB 2006 ASPET Awards Winners at EB 2006 Inside this Issue: ASPET Election Online EB ’07 Program Grid Neuropharmacology Division Mixer at SFN 2006 New England Chapter Meeting Summary SEPS Meeting Summary and Abstracts MAPS Meeting Summary and Abstracts Call for Late-Breaking Abstracts for EB‘07 A Publication of the American Society for 121 Pharmacology and Experimental Therapeutics - ASPET Volume 48 Number 4, 2006 The Pharmacologist is published and distributed by the American Society for Pharmacology and Experimental Therapeutics. The Editor PHARMACOLOGIST Suzie Thompson EDITORIAL ADVISORY BOARD Bryan F. Cox, Ph.D. News Ronald N. Hines, Ph.D. Terrence J. Monks, Ph.D. 2006 Year in Review page 123 COUNCIL . President Contributors for 2006 . page 124 Elaine Sanders-Bush, Ph.D. Election 2007 . President-Elect page 126 Kenneth P. Minneman, Ph.D. EB 2007 Program Grid . page 130 Past President James E. Barrett, Ph.D. Features Secretary/Treasurer Lynn Wecker, Ph.D. Secretary/Treasurer-Elect Journals . Annette E. Fleckenstein, Ph.D. page 132 Past Secretary/Treasurer Public Affairs & Government Relations . page 134 Patricia K. Sonsalla, Ph.D. Division News Councilors Bryan F. Cox, Ph.D. Division for Neuropharmacology . page 136 Ronald N. Hines, Ph.D. Centennial Update . Terrence J. Monks, Ph.D. page 137 Chair, Board of Publications Trustees Members in the News .
    [Show full text]
  • Memorandum Date: June 6, 2014
    DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Memorandum Date: June 6, 2014 From: Bisphenol A (BPA) Joint Emerging Science Working Group Smita Baid Abraham, M.D. ∂, M. M. Cecilia Aguila, D.V.M. ⌂, Steven Anderson, Ph.D., M.P.P.€* , Jason Aungst, Ph.D.£*, John Bowyer, Ph.D. ∞, Ronald P Brown, M.S., D.A.B.T.¥, Karim A. Calis, Pharm.D., M.P.H. ∂, Luísa Camacho, Ph.D. ∞, Jamie Carpenter, Ph.D.¥, William H. Chong, M.D. ∂, Chrissy J Cochran, Ph.D.¥, Barry Delclos, Ph.D.∞, Daniel Doerge, Ph.D.∞, Dongyi (Tony) Du, M.D., Ph.D. ¥, Sherry Ferguson, Ph.D.∞, Jeffrey Fisher, Ph.D.∞, Suzanne Fitzpatrick, Ph.D. D.A.B.T. £, Qian Graves, Ph.D.£, Yan Gu, Ph.D.£, Ji Guo, Ph.D.¥, Deborah Hansen, Ph.D. ∞, Laura Hungerford, D.V.M., Ph.D.⌂, Nathan S Ivey, Ph.D. ¥, Abigail C Jacobs, Ph.D.∂, Elizabeth Katz, Ph.D. ¥, Hyon Kwon, Pharm.D. ∂, Ifthekar Mahmood, Ph.D. ∂, Leslie McKinney, Ph.D.∂, Robert Mitkus, Ph.D., D.A.B.T.€, Gregory Noonan, Ph.D. £, Allison O’Neill, M.A. ¥, Penelope Rice, Ph.D., D.A.B.T. £, Mary Shackelford, Ph.D. £, Evi Struble, Ph.D.€, Yelizaveta Torosyan, Ph.D. ¥, Beverly Wolpert, Ph.D.£, Hong Yang, Ph.D.€, Lisa B Yanoff, M.D.∂ *Co-Chair, € Center for Biologics Evaluation & Research, £ Center for Food Safety and Applied Nutrition, ∂ Center for Drug Evaluation and Research, ¥ Center for Devices and Radiological Health, ∞ National Center for Toxicological Research, ⌂ Center for Veterinary Medicine Subject: 2014 Updated Review of Literature and Data on Bisphenol A (CAS RN 80-05-7) To: FDA Chemical and Environmental Science Council (CESC) Office of the Commissioner Attn: Stephen M.
    [Show full text]
  • Phytoalexins: Current Progress and Future Prospects
    Phytoalexins: Current Progress and Future Prospects Edited by Philippe Jeandet Printed Edition of the Special Issue Published in Molecules www.mdpi.com/journal/molecules Philippe Jeandet (Ed.) Phytoalexins: Current Progress and Future Prospects This book is a reprint of the special issue that appeared in the online open access journal Molecules (ISSN 1420-3049) in 2014 (available at: http://www.mdpi.com/journal/molecules/special_issues/phytoalexins-progress). Guest Editor Philippe Jeandet Laboratory of Stress, Defenses and Plant Reproduction U.R.V.V.C., UPRES EA 4707, Faculty of Sciences, University of Reims, PO Box. 1039, 51687 Reims cedex 02, France Editorial Office MDPI AG Klybeckstrasse 64 Basel, Switzerland Publisher Shu-Kun Lin Managing Editor Ran Dang 1. Edition 2015 MDPI • Basel • Beijing ISBN 978-3-03842-059-0 © 2015 by the authors; licensee MDPI, Basel, Switzerland. All articles in this volume are Open Access distributed under the Creative Commons Attribution 3.0 license (http://creativecommons.org/licenses/by/3.0/), which allows users to download, copy and build upon published articles even for commercial purposes, as long as the author and publisher are properly credited, which ensures maximum dissemination and a wider impact of our publications. However, the dissemination and distribution of copies of this book as a whole is restricted to MDPI, Basel, Switzerland. III Table of Contents About the Editor ............................................................................................................... VII List of
    [Show full text]
  • ABSTRACT Title of Document: BIOLOGICAL
    ABSTRACT Title of Document: BIOLOGICAL EFFICACY, MECHANISMS OF ACTIONS OF SOY-DERIVED PHYTOALEXIN GLYCEOLLINS IN PREVENTION OF CHRONIC DISEASES Haiqiu Huang, Doctor of Philosophy, 2014 Directed By: Professor Liangli (Lucy) Yu Department of Nutrition and Food Science Cardiovascular disease (CVD) is the leading cause of deaths worldwide. Prostate cancer is the most prevalent cancer in U.S. male population. Diet-induced hypercholesterolemia and chronic inflammation promote the development of both CVD and prostate cancer. Glyceollins are a group of soy phytoalexins possessing a variety of biological activities. This research project focused on characterizing glyceollins’ bioactivities in alleviating cholesterol dysregulation, prevention of prostate cancer, and regulating gut microbiome. The first part of the project aimed to evaluate glyceollins’ cholesterol- lowering effect in-vivo. Male golden Syrian hamsters were fed high-fat diet with or without glyceollins supplementation for 28 days. Glyceollins supplementation led to a significant reduction of plasma VLDL, hepatic cholesterol esters and total lipid content. Consistent with changes in circulating cholesterol, glyceollins supplementation also altered expression of the genes related to cholesterol metabolism in the liver. The second part of the study aimed to evaluate glyceollins’ effect in reducing prostate cancer tumor growth in a xenograft model. An initial delayed appearance of tumor was observed in a PC-3 xenograft model. However, no difference in tumor sizes was observed in a LNCaP xenograft model. Extrapolation analysis of tumor measurements indicated that no difference in sizes was expected for both PC-3 and LNCaP tumors. Glyceollins had no effect on the androgen responsive pathway, its proliferation, cell cycle, or on angiogenesis genes in tumor and xenobiotic metabolism, cholesterol transport, and inflammatory cytokine genes in liver.
    [Show full text]
  • Coumestrol Suppresses Proliferation of ES2 Human Epithelial Ovarian Cancer Cells
    W LIM, W JEONG and others Coumestrol inhibits progression 228:3 149–160 Research of EOC Coumestrol suppresses proliferation of ES2 human epithelial ovarian cancer cells Whasun Lim1,*, Wooyoung Jeong2,* and Gwonhwa Song1 1Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 136-713, Correspondence Republic of Korea should be addressed 2Department of Animal Resources Science, Dankook University, Cheonan 330-714, to G Song Republic of Korea Email *(W Lim and W Jeong contributed equally to this work) [email protected] Abstract Coumestrol, which is predominantly found in soybean products as a phytoestrogen, Key Words has cancer preventive activities in estrogen-responsive carcinomas. However, effects and " ovary molecular targets of coumestrol have not been reported for epithelial ovarian cancer (EOC). " reproduction In the present study, we demonstrated that coumestrol inhibited viability and invasion and " reproductive tract induced apoptosis of ES2 (clear cell-/serous carcinoma origin) cells. In addition, immuno- " coumestrol reactive PCNA and ERBB2, markers of proliferation of ovarian carcinoma, were attenuated in " clear cell carcinoma their expression in coumestrol-induced death of ES2 cells. Phosphorylation of AKT, p70S6K, ERK1/2, JNK1/2, and p90RSK was inactivated by coumestrol treatment in a dose- and time- dependent manner as determined in western blot analyses. Moreover, PI3K inhibitors Journal of Endocrinology enhanced effects of coumestrol to decrease phosphorylation of AKT, p70S6K, S6, and ERK1/2. Furthermore, coumestrol has strong cancer preventive effects as compared to other conventional chemotherapeutics on proliferation of ES2 cells. In conclusion, coumestrol exerts chemotherapeutic effects via PI3K and ERK1/2 MAPK pathways and is a potentially novel treatment regimen with enhanced chemoprevention activities against progression of EOC.
    [Show full text]
  • 10/12/2019 Herbal Preparations with Phytoestrogens- Overview of The
    Herbal preparations with phytoestrogens- overview of the adverse drug reactions Introduction For women suffering from menopausal symptoms, treatment is available if the symptoms are particularly troublesome. The main treatment for menopausal symptoms is hormone replacement therapy (HRT), although other treatments are also available for some of the symptoms (1). In recent years, the percentage of women taking hormone replacement therapy has dropped (2, 3). Many women with menopausal symptoms choose to use dietary supplements on a plant-based basis, probably because they consider these preparations to be "safe" (4). In addition to product for relief of menopausal symptoms, there are also preparations on the market that claim to firm and grow the breasts by stimulating the glandular tissue in the breasts (5). All these products contain substances with an estrogenic activity, also called phytoestrogens. These substances are found in a variety of plants (4). In addition, also various multivitamin preparations are on the market that, beside the vitamins and minerals, also contain isoflavonoids. Because those are mostly not specified and present in small quantities and no estrogenic effect is to be expected, they are not included in this overview. In 2015 and 2017 the Netherlands Pharmacovigilance Centre Lareb informed the Netherlands Food and Consumer Product Safety Authority (NVWA) about the received reports of Post-Menopausal Vaginal Hemorrhage Related to the Use of a Hop-Containing Phytotherapeutic Products MenoCool® and Menohop® (6, 7). Reports From September 1999 until November 2019 the Netherlands Pharmacovigilance Centre Lareb received 51 reports of the use of phytoestrogen containing preparations (see Appendix 1). The reports concern products with various herbs to which an estrogenic effect is attributed.
    [Show full text]
  • Appendix 1 – Protocol for Preventing Or Reversing Chronic Disease The
    Appendix 1 – Protocol for Preventing or Reversing Chronic Disease The first author has developed a protocol over the past decade for preventing or reversing chronic disease based on the following systemic medical principle: “at the present time, removal of cause is a necessary, but not necessarily sufficient, condition for restorative treatment to be effective”[1]. The protocol methodology refines the age-old principles of both reducing harm in addition to providing treatment, and allows better identification of factors that contribute to the disease process (so that they may be eliminated if possible). These contributing factors are expansive and may include a combination of Lifestyle choices (diet, exercise, smoking), iatrogenic and biotoxin exposures, environmental/occupational exposures, and psychosocial stressors. This strategy exploits the existing literature to identify patterns of biologic response using biomarkers from various modalities of diagnostic testing to capture a much broader list of potential contributing factors. Existing inflammatory bowel diseases (IBD) Biomarker Identification to Remove Contributing Factors and Implement Treatment The initial protocol steps are diagnostic. The main output of these diagnostics will be identification of the biomarker levels and symptoms that reflect abnormalities, and the directions of change required to eliminate these abnormalities. In the present study, hundreds of general and specific biomarkers and symptoms were identified from the core IBD literature. The highest frequency (based on numbers of record appearances) biomarkers and symptoms were extracted, and are listed in Table 1 (highest frequency items first, reading down each column before proceeding to the next column). They are not necessarily consensus biomarkers. They are biomarkers whose values were altered by a treatment or contributing factor, and reported in the core IBD literature.
    [Show full text]
  • Phytoestrogen Concentrations in Serum and Spot
    698 Cancer Epidemiology, Biomarkers & Prevention Phytoestrogen Concentrations in Serum and Spot Urine as Biomarkers for Dietary Phytoestrogen Intake and Their Relation to Breast Cancer Risk in European Prospective Investigation of Cancer and Nutrition-Norfolk Philip B. Grace,1 James I. Taylor,1 Yen-Ling Low,1 Robert N. Luben,2 Angela A. Mulligan,2 Nigel P. Botting,3 Mitch Dowsett,4 Ailsa A. Welch,2 Kay-Tee Khaw,2 Nick J. Wareham,2 Nick E. Day,2 and Sheila A. Bingham1,2 1MRC Dunn Human Nutrition Unit, Cambridge, United Kingdom; 2European Prospective Investigation of Cancer and Nutrition, Institute of Public Health and Strangeways Research Laboratories, Cambridge, United Kingdom; 3School of Chemistry, University of St. Andrews, Fife, United Kingdom; and 4Royal Marsden Hospital, London, United Kingdom Abstract Subjects of this study consisted of 333 women (aged 45– creatinine) correlated strongly with that in serum, with 75 years) drawn from a large United Kingdom prospec- Pearson correlation coefficients > 0.8. There were sig- tive study of diet and cancer, the European Prospective nificant relationships (P < 0.02) between both urinary Investigation of Cancer and Nutrition-Norfolk study. and serum concentrations of isoflavones across increas- Using newly developed gas chromatography/mass ing tertiles of dietary intakes. Urinary enterodiol and spectrometry and liquid chromatography/mass spectro- enterolactone and serum enterolactone were signifi- metry methods incorporating triply 13C-labeled stand- cantly correlated with dietary fiber intake (r =0.13– ards, seven phytoestrogens (daidzein, genistein, 0.29). Exposure to all isoflavones was associated with glycitein, O-desmethylangolensin, equol, enterodiol, increased breast cancer risk, significantly so for equol and enterolactone) were measured in 114 spot urines and daidzein.
    [Show full text]
  • Isoflavonoid Biosynthesis 21321.Pdf
    Isoflavonoid Biosynthesis https://www.kegg.jp/kegg-bin/highlight_pathway?scale=1.0&map=map00943&keyword=flavonoids Isoflavonoids are biologically active compounds, such as phytoestrogens, produced by pea family plants. While flavonoids (in the narrow sense) have the 2- phenylchromen-4-one backbone, isoflavonoids have the 3-phenylchromen-4-one backbone with no hydroxyl group substitution at position 2. Isoflavonoids are derived from the flavonoid biosynthesis pathway via liquiritigenin or naringenin. (Flavonoid Biosynthesis) -> [1,2] 1) Liquiritigenin -> [1,2,3] 1) flavone synthesis I & II -> 7,4’Dihydroxyflavone OR 2) flavonoid 6-hydroxylase -> 6,7,4’-Trihydroxyflavanone -> 2- hydroxyisoflavone synthase -> 2,6,7,4’-tetrahydroxyisoflavanone -> 6- Hydroxydaidzein -> Glycitein -> isoflavone 7-O-glucosyltransferase -> Glycitein 7-O-glucoside -> isoflavone 7-O-glucoside-6’’-O-malonyltransferase -> Glycitein 7-O-glucoside-6”-O-malonate OR 3) 2-hydroxyisoflavanone synthase -> 2,7,4’Trihydroxyisoflavanone -> [1,2] 1) Feedback Loop 2,7,4’-trihydroxyisoflavanone 4’-O-methyltransferase / isoflavone 4’-O-methyltransferase -> 2,7-Dihydroxy-4’-methoxyisoflavanone -> 2- hydroxyisoflavanone dehydratase -> Formononetin OR 2) 2-hydroxyisoflavone dehydratase -> Daidzein -> [1,2,3,4,5] 1) isoflavone/4’-methoxyisoflavone 2’-hydroxylase -> 2’Hydroxydaidzein -> 2’Hydroxydaidzein reductase -> 2’-Hydroxydihydrodaidzein -> 3,9-Dihydroxypterocarpan -> 3,9-dihydroxypterocarpan 6a-monooxygenase -> 3,6,9- Trihydroxypterocarpan -> [1,2] 1) trihydroxypterocarpan dimethylallyltransferase
    [Show full text]
  • The Influence of Plant Isoflavones Daidzein and Equol on Female
    pharmaceuticals Review The Influence of Plant Isoflavones Daidzein and Equol on Female Reproductive Processes Alexander V. Sirotkin 1,* , Saleh Hamad Alwasel 2 and Abdel Halim Harrath 2 1 Department of Zoology and Anthropology, Constantine the Philosopher University in Nitra, 949 01 Nitra, Slovakia 2 Department of Zoology, College of Science, King Saud University, Riyadh 12372, Saudi Arabia; [email protected] (S.H.A.); [email protected] (A.H.H.) * Correspondence: [email protected]; Tel.: +421-903561120 Abstract: In this review, we explore the current literature on the influence of the plant isoflavone daidzein and its metabolite equol on animal and human physiological processes, with an emphasis on female reproduction including ovarian functions (the ovarian cycle; follicullo- and oogenesis), fundamental ovarian-cell functions (viability, proliferation, and apoptosis), the pituitary and ovarian endocrine regulators of these functions, and the possible intracellular mechanisms of daidzein action. Furthermore, we discuss the applicability of daidzein for the control of animal and human female reproductive processes, and how to make this application more efficient. The existing literature demonstrates the influence of daidzein and its metabolite equol on various nonreproductive and reproductive processes and their disorders. Daidzein and equol can both up- and downregulate the ovarian reception of gonadotropins, healthy and cancerous ovarian-cell proliferation, apoptosis, viability, ovarian growth, follicullo- and oogenesis, and follicular atresia. These effects could be mediated by daidzein and equol on hormone production and reception, reactive oxygen species, and intracellular regulators of proliferation and apoptosis. Both the stimulatory and the inhibitory Citation: Sirotkin, A.V.; Alwasel, effects of daidzein and equol could be useful for reproductive stimulation, the prevention and S.H.; Harrath, A.H.
    [Show full text]